Information om | Engelska ordet AMIVANTAMAB

Exempel på hur man kan använda AMIVANTAMAB i en mening

• The US Food and Drug Administration (FDA) approved amivantamab based on CHRYSALIS, a multicenter, non-randomized, open label, multicohort clinical trial (NCT02609776) which included participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations.

Förberedelsen av sidan tog: 126,53 ms.